Price E et al. |
A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL. |
2014 |
Blood Cells Mol. Dis. |
pmid:25065855
|
Kuo KL et al. |
Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. |
2014 |
J. Am. Soc. Nephrol. |
pmid:24722448
|
Macdougall IC et al. |
A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD. |
2014 |
Clin J Am Soc Nephrol |
pmid:24458078
|
Contreras C et al. |
Comparative study of the oral absorption of microencapsulated ferric saccharate and ferrous sulfate in humans. |
2014 |
Eur J Nutr |
pmid:23892521
|
Corwin HL and Napolitano LM |
Anemia in the critically ill: do we need to live with it?*. |
2014 |
Crit. Care Med. |
pmid:25126804
|
Pieracci FM et al. |
A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*. |
2014 |
Crit. Care Med. |
pmid:24797376
|
Hetzel D et al. |
A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. |
2014 |
Am. J. Hematol. |
pmid:24639149
|
Perelló MF et al. |
Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial. |
2014 |
BJOG |
pmid:24423186
|
Toyokuni S |
Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis. |
2014 |
Redox Rep. |
pmid:24257681
|
Onken JE et al. |
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. |
2014 |
Nephrol. Dial. Transplant. |
pmid:23963731
|